Sun Pharmaceutical Industries Ltd Quarterly Result

Sun Pharmaceutical Industries Ltd Quarterly Result

Image

Sun Pharmaceutical Industries Ltd

NSE: SUNPHARMA

Net Profit - Last Quarter

₹ 2723.72 Cr.

Last updated on: Jun 03, 2026

Sun Pharmaceutical Industries Ltd Quarterly Results Key Highlights

  • The revenue of Sun Pharmaceutical Industries Ltd for the Mar '26 is ₹ 15070 crore as compare to the Dec '25 revenue of ₹ 16099 crore.
  • This represent the decline of -6.39% The ebitda of Sun Pharmaceutical Industries Ltd for the Mar '26 is ₹ 4412 crore as compare to the Dec '25 ebitda of ₹ 5037 crore.
  • This represent the decline of -12.41% The net profit of Sun Pharmaceutical Industries Ltd for the Mar '26 is ₹ 2723 crore as compare to the Dec '25 net profit of ₹ 3401 crore.
  • This represent the decline of -19.92%.

Sun Pharmaceutical Industries Ltd Quarterly Results Analysis

Market Price of Sun Pharmaceutical Industries Ltd

1M

1Y

3Y

5Y

Monitoring Sun Pharmaceutical Industries Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
03 Jun 20261789.45
02 Jun 20261789.95
01 Jun 20261795.95
29 May 20261800.9
27 May 20261845
26 May 20261840.55
25 May 20261841.3
22 May 20261845.2
21 May 20261891.15
20 May 20261880.5

Historical Revenue of Sun Pharmaceutical Industries Ltd

No data available

* All values are in crore

Historical EBITDA of Sun Pharmaceutical Industries Ltd

No data available

* All values are in crore

Historical Net Profit of Sun Pharmaceutical Industries Ltd

No data available

* All values are in crore

Sun Pharmaceutical Industries Ltd News Hub

Sun Pharmaceuticals Industries Ltd spurts 0.31%, up for fifth straight session

Sun Pharmaceuticals Industries Ltd gained for a fifth straight session today. The stock is quoting a

Read more

20 Aug 24

Sun Pharmaceutical to invest USD 15 mn in Pharmazz Inc.

Sun Pharmaceutical Industries has entered into an agreement with Pharmazz Inc. Delaware US, pursuant

Read more

14 Aug 24

Sun Pharma Q1 PAT climbs 40% YoY to Rs 2,835 cr

Profit before tax was at Rs 3,423.5 crore in Q1 FY25, registering a growth of 37.98% on YoY basis. D

Read more

01 Aug 24

Sun Pharmaceuticals Industries consolidated net profit rises 40.20% in the June 2024 quarter

Net profit of Sun Pharmaceuticals Industries rose 40.20% to Rs 2835.62 crore in the quarter ended Ju

Read more

01 Aug 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

July 2024

PPT

May 2024

Transcript

Mar 2024

PPT

Feb 2024

Transcript

Jan 2024

PPT

Nov 2023

Transcript

Sep 2023

PPT

May 2023

Transcript

Apr 2023

PPT

Nov 2022

Transcript

Sep 2022

PPT

Aug 2022

Transcript

June 2022

Transcript

Mar 2022

PPT

Feb 2022

Transcript

About Sun Pharmaceutical Industries Ltd

  • Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
  • The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
  • It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
  • The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

FAQs for Quarterly Results of Sun Pharmaceutical Industries Ltd

What key financial metrics are included in Sun Pharmaceutical Industries Ltd's quarterly results?

Key financial metrics in Sun Pharmaceutical Industries Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Sun Pharmaceutical Industries Ltd announce its quarterly results?

Sun Pharmaceutical Industries Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Sun Pharmaceutical Industries Ltd's quarterly performance impact its stock price?

Sun Pharmaceutical Industries Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Sun Pharmaceutical Industries Ltd's quarterly results on dividends?

The impact of Sun Pharmaceutical Industries Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Sun Pharmaceutical Industries Ltd's quarterly results?

Yes, Sun Pharmaceutical Industries Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions